|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,630,000,000 |
Market
Cap: |
392.19(B) |
Last
Volume: |
10,114,860 |
Avg
Vol: |
8,309,526 |
52
Week Range: |
$144.45 - $174.48 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
|
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
MAJOR MARKET |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 21 |
Guru Rank Value : 20.3 |
Guru Occurances : 6 |
|
|
|
|
|
|
|
Company Profile Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
68,288 |
68,288 |
115,451 |
551,869 |
Total Sell Value |
$10,723,734 |
$10,723,734 |
$18,652,688 |
$94,297,224 |
Total People Sold |
2 |
2 |
5 |
10 |
Total Sell Transactions |
2 |
2 |
5 |
25 |
End Date |
2024-01-21 |
2023-10-20 |
2023-04-21 |
2022-04-21 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
|
2024-03-13 |
4 |
S |
$162.16 |
$1,441,765 |
D/D |
(8,891) |
15,043 |
|
8% |
|
Schmid Timothy |
EVP, WW Chair, MedTech |
|
2024-02-13 |
4 |
D |
$157.85 |
$39,463 |
D/D |
(250) |
13,040 |
|
- |
|
Schmid Timothy |
EVP, WW Chair, MedTech |
|
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
499 |
13,290 |
|
- |
|
Swanson James D. |
EVP, CIO |
|
2024-02-13 |
4 |
D |
$157.85 |
$30,781 |
D/D |
(195) |
14,570 |
|
- |
|
Swanson James D. |
EVP, CIO |
|
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
447 |
14,765 |
|
- |
|
Hait William |
See Remarks |
|
2024-02-13 |
4 |
D |
$157.85 |
$67,402 |
D/D |
(427) |
38,647 |
|
- |
|
Hait William |
See Remarks |
|
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
834 |
39,074 |
|
- |
|
Wolk Joseph J |
Exec VP, CFO |
|
2024-02-13 |
4 |
D |
$157.85 |
$122,018 |
D/D |
(773) |
68,890 |
|
- |
|
Wolk Joseph J |
Exec VP, CFO |
|
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,780 |
69,663 |
|
- |
|
Broadhurst Vanessa |
EVP, Global Corp Affairs |
|
2024-02-13 |
4 |
D |
$157.85 |
$32,991 |
D/D |
(209) |
23,934 |
|
- |
|
Broadhurst Vanessa |
EVP, Global Corp Affairs |
|
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
408 |
24,143 |
|
- |
|
Wengel Kathryn E |
EVP, Chief TO and Risk Officer |
|
2024-02-13 |
4 |
D |
$157.85 |
$52,564 |
D/D |
(333) |
82,266 |
|
- |
|
Wengel Kathryn E |
EVP, Chief TO and Risk Officer |
|
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
651 |
82,599 |
|
- |
|
Taubert Jennifer L |
EVP, WWC. Innovative Medicine |
|
2024-02-13 |
4 |
D |
$157.85 |
$105,128 |
D/D |
(666) |
154,851 |
|
- |
|
Taubert Jennifer L |
EVP, WWC. Innovative Medicine |
|
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,302 |
155,517 |
|
- |
|
Duato Joaquin |
CEO and Chairman of the Board |
|
2024-02-13 |
4 |
D |
$157.85 |
$237,880 |
D/D |
(1,507) |
363,302 |
|
- |
|
Duato Joaquin |
CEO and Chairman of the Board |
|
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,470 |
364,809 |
|
- |
|
Fasolo Peter |
Exec VP, Chief HR Officer |
|
2024-02-13 |
4 |
D |
$157.85 |
$74,821 |
D/D |
(474) |
112,076 |
|
- |
|
Fasolo Peter |
Exec VP, Chief HR Officer |
|
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
925 |
112,550 |
|
- |
|
Forminard Elizabeth |
Executive VP, General Counsel |
|
2024-02-13 |
4 |
D |
$157.85 |
$37,253 |
D/D |
(236) |
8,340 |
|
- |
|
Forminard Elizabeth |
Executive VP, General Counsel |
|
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
651 |
8,576 |
|
- |
|
Decker Robert J |
VP Corporate Controller |
|
2024-02-13 |
4 |
D |
$157.85 |
$13,575 |
D/D |
(86) |
18,973 |
|
- |
|
Decker Robert J |
VP Corporate Controller |
|
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
313 |
19,059 |
|
- |
|
Schmid Timothy |
EVP, WW Chair, MedTech |
|
2024-02-12 |
4 |
D |
$157.40 |
$454,414 |
D/D |
(2,887) |
12,791 |
|
- |
|
Schmid Timothy |
EVP, WW Chair, MedTech |
|
2024-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,736 |
15,678 |
|
- |
|
1524 Records found
|
|
Page 1 of 61 |
|
|